--Regeneron Pharmaceuticals, Inc. and Sanofi today presented positive results from the clinical trial assessing Dupixent ® in adults and adolescents with uncontrolled moderate-to-severe atopic hand ...
The American Academy of Dermatology (AAD) recently issued a focused update to its guidelines on the management of atopic dermatitis (AD) in adults, strongly recommending four recently approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results